Onderneming Fennec Pharmaceuticals Inc.
Aandelen
FENC
CA31447P1009
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,09 USD | 0,00% | -0,76% | -18,98% |
Vakgebied
Aantal werknemers: 29
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07-07-09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07-07-09 |
Chief Tech/Sci/R&D Officer | - | - | |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25-04-14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 01-11-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25-08-11 |
Khalid Islam
CHM | Chairman | 67 | 25-04-14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07-07-09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25-04-14 |
Marco Brughera
BRD | Director/Board Member | 70 | 10-08-16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07-07-09 |
Jodi Cook
BRD | Director/Board Member | 56 | 24-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 099 908 | 22 955 300 ( 84,71 %) | 0 | 84,71 % |
Bedrijfsgegevens
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,98% | 246 mln. | |
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers FENC
- Onderneming Fennec Pharmaceuticals Inc.